TELO — Telo Genomics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Telo Genomics, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	—	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	3.64	2.69	2.67	0.796	0.789
Net Total Accounts Receivable
Net Total Receivables	0.097	0.038	0.064	0.031	0.027
Prepaid Expenses
Total Current Assets	3.76	2.79	2.84	0.919	0.892
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.062	0.03	0.066	0.03	0.019
Net Intangible Assets
Total Assets	3.84	2.83	2.93	0.966	0.911
Payable / Accrued
Notes Payable / Short Term Debt
Total Current Liabilities	0.114	0.19	0.28	0.376	0.396
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	0.154	0.23	0.313	0.376	0.396
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	3.69	2.6	2.61	0.59	0.515
Total Liabilities & Shareholders' Equity	3.84	2.83	2.93	0.966	0.911
Total Common Shares Outstanding